Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis. (2011)

First Author: Sadnicka A


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp.2009.174888

PubMed Identifier: 20462915

Publication URI: http://europepmc.org/abstract/MED/20462915

Type: Journal Article/Review

Volume: 82

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 2

ISSN: 0022-3050